EBITDA: Income before interest, taxes, depreciation and amortization.
Mereo BioPharma Group plc - Sponsored ADR (MREO) had EBITDA of $-10.46M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-7.02M |
|
-- |
|
-- |
|
$10.31M |
|
$-10.31M |
|
$3.29M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
$-7.02M |
|
$-10.31M |
|
|
EBITDA |
$-10.46M |
159.99M |
|
159.99M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$52.41M |
|
$0.17M |
|
$1.20M |
|
$53.60M |
|
$6.02M |
|
-- |
|
$0.99M |
|
$7.00M |
|
$46.60M |
|
$45.95M |
|
$46.60M |
|
159.10M |
|
| Cash Flow Statement Financials | |
$-23.29M |
|
$-0.02M |
|
$0.29M |
|
$69.80M |
|
$48.70M |
|
$-21.10M |
|
$6.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.71 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.07% |
|
-15.28% |
|
-13.10% |
|
-15.07% |
|
$0.29 |
|
$-0.15 |
|
$-0.15 |
|